Pulmonary fibrosis (PF) is a disease-refractive lung condition with an increased rate of
mortality. The potential factors causing PF include viral infections, radiation exposure, and …

Pulmonary fibrosis (PF) is the devastating consequence of various inflammatory diseases of
the lung. PF leads to a reduction of lung function, respiratory failure, and death. Several …

Pulmonary fibrosis is an incurable end-stage lung disease and remains a global public
health problem. Although there have been some breakthroughs in understanding the …

Pulmonary fibrosis (PF) is a highly confounding and fatal pathological process with finite
treatment options. Multiple factors such as oxidative and immune/inflammation involve key …

Ethnic pharmacological relevance Pulmonary fibrosis (PF) is a fibrotic interstitial lung
disease caused by continuous damage and excessive repair of alveolar epithelial cells, the …

Idiopathic pulmonary fibrosis (IPF), a tumor-like disease, is a serious and fatal pulmonary
inflammatory condition usually characterized by irreversible destruction of the lung …

Pulmonary fibrosis (PF) is a lethal, chronic and progressive respiratory disease leading to
interstitial lung damage and serious breathing problems. The pathogenic mechanism …

Pulmonary fibrosis (PF) is a chronic and irreversible pulmonary disease, and can lead to
decreased lung function, respiratory failure and even death. The pathogenesis research and …

Idiopathic pulmonary fibrosis (IPF) is a devastating and common chronic lung disease
pathologically characterized by loss of epithelial cells and activation of fibroblasts and …

Natural products are one of the best sources for the discovery of novel drugs and
compounds for multiple diseases. Pulmonary fibrosis (PF) is a chronic, progressive …